View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Infection News

SPONSORED CONTENT
November 18, 2024
2 min read
Save
9 stories for Antibiotic Awareness Week

9 stories for Antibiotic Awareness Week

Each year, from Nov. 18 to Nov. 24, the CDC’s U.S. Antibiotic Awareness Week raises awareness about antimicrobial resistance and encourages the appropriate use of antibiotics and antifungals.

SPONSORED CONTENT
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

CDC: 1 dead in multistate outbreak of <i>E. coli</i> linked to organic carrots

One person has died and 15 have been hospitalized in a multistate outbreak of Escherichia coli linked to consuming organic carrots, the CDC announced.

SPONSORED CONTENT
November 12, 2024
3 min read
Save

‘Change the HDV narrative’: A call to heighten awareness, prioritize early detection

&lsquo;Change the HDV narrative&rsquo;: A call to heighten awareness, prioritize early detection

As you read these words, you may be learning for the first time about hepatitis delta virus — a lesser-known type of hepatitis that is potentially life-threatening.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
November 08, 2024
3 min watch
Save

VIDEO: Rebyota effective in prevention of recurrent C. diff, even in higher risk patients

VIDEO: Rebyota effective in prevention of recurrent <i>C. diff</i>,<i> </i>even in higher risk patients

PHILADELPHIA — Rebyota was safe and effective at 8 weeks and up to 6 months in patients with recurrent Clostridioides difficile infection, many of whom had other gastrointestinal comorbidities and risk factors, according to data presented.

SPONSORED CONTENT
November 06, 2024
2 min read
Save

‘No clear efficacy benefit’ to combining bezlotoxumab with FMT in IBD, recurrent C. diff

&lsquo;No clear efficacy benefit&rsquo; to combining bezlotoxumab with FMT in IBD, recurrent <i>C. diff</i>

PHILADELPHIA — Bezlotoxumab in combination with fecal microbiota transplantation did not further reduce recurrence of Clostridioides difficile infection in patients with inflammatory bowel disease, according to data presented here.

SPONSORED CONTENT
November 04, 2024
2 min read
Save

‘Some may die’: AGA urges continued access to conventional FMT for C. difficile patients

&lsquo;Some may die&rsquo;: AGA urges continued access to conventional FMT for <i>C. difficile</i><i> </i>patients

OpenBiome will continue distribution of investigational fecal microbiota transplantation through 2024, as suspension may put certain patients with recurrent, refractory or fulminant Clostridioides difficile at risk, according to the AGA.

SPONSORED CONTENT
November 01, 2024
2 min read
Save

CDC’s Social Vulnerability Index predicts CDI severity, mortality

CDC&rsquo;s Social Vulnerability Index predicts CDI severity, mortality

The four core concepts of the CDC’s Social Vulnerability Index could be used to predict the severity of Clostrioides difficile infection and all-cause mortality, according to a study presented at IDWeek.

SPONSORED CONTENT
October 25, 2024
1 min read
Save

CDC announces more cases, states in E. coli outbreak linked to McDonald’s burgers

CDC announces more cases, states in <i>E. coli </i>outbreak linked to McDonald&rsquo;s burgers

The CDC on Friday announced 26 more cases in the multistate outbreak of Escherichia coli linked to McDonald’s Quarter Pounders, bringing the total to 75 cases in 13 states.

SPONSORED CONTENT
October 22, 2024
1 min read
Save

CDC: 1 dead in multistate E. coli outbreak linked to McDonald’s Quarter Pounders

CDC: 1 dead in multistate <i>E. coli </i>outbreak linked to McDonald&rsquo;s Quarter Pounders

One person has died and 10 have been hospitalized in a multistate outbreak of Escherichia coli infections linked to McDonald’s Quarter Pounders, the CDC said Tuesday.

SPONSORED CONTENT
October 19, 2024
2 min read
Save

Computer prompt cuts extended-spectrum antibiotic use for abdominal infections by 35%

Computer prompt cuts extended-spectrum antibiotic use for abdominal infections by 35%

LOS ANGELES — A computer prompt recommending appropriate antibiotic use based on a patient’s level of risk for a resistant infection cut the use of extended-spectrum antibiotics for abdominal infections by around one-third in a large trial.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails